HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 193-204 of 1,979
Drug study icon
WithdrawnNCT01124877

Safety study of flexible Doses Of Oral Ziprasidone in Bipolarity

Official study title

26 Week Open Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)

This study was withdrawn before enrollment.

Location not clearly listed
BipolarityMedication studyAges 10–17
Countries
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Behavioral study icon
UnknownNCT06282250

Seeing the Light: Early Intervention in People at Risk for Bipolarity

Official study title

An Explorative and Experimental Study to Assess the Feasibility, Acceptability, and Effectiveness of Early Intervention With Light, Lifestyle and ImCT Therapy in Individuals at Risk for Bipolar Disorder

Current recruitment status is unconfirmed.

In Eindhoven
BipolarityBehavioural studyAges 16–35
Countries
Netherlands
Sponsor
Geestelijke Gezondheidszorg Eindhoven (GGzE)
Drug study icon
CompletedNCT00721955

Staccato Loxapine in Agitated people with Bipolarity

What is this study about?

Researchers compared Inhaled loxapine 5 mg, Inhaled loxapine 10 mg and placebo to find out how the approaches affected psychotic symptoms in people with bipolarity type I.

This study has finished and is no longer accepting participants.

Multiple locations, including Escondido
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
Alexza Pharmaceuticals, Inc.
Drug study icon
CompletedNCT00076115

Effectiveness of risperidone in Bipolarity

What is this study about?

This study evaluated the safety and effectiveness of Risperidone for people with bipolarity.

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityMedication studyAges 10–17
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Behavioral study icon
CompletedNCT06113887

The Effect of Acceptance and Commitment of Bipolarity Patients

Official study title

The Effect of Acceptance and Commitment Therapy Based Psychoeducation on Psychological Flexibility and Impulsivity Levels in Bipolar Disorder Patients

This study has finished and is no longer accepting participants.

In Gaziantep
BipolarityInterventional studyAges 18–65
Countries
Türkiye
Sponsor
University of Gaziantep

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.